RB1 and cancer: At present, some Rb-associated metabolic enzymes, such as lactate dehydrogenase (LDH), glucose transporter 1 (Glut1) and 6-phosphofructo-2-kinase (PFKFB), are suggested to be potential targets for Rb-deficient cancer cells [3].